These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 504962)

  • 1. High level of human growth hormone (HGH) in cerebrospinal fluid patients with pituitary tumors.
    Coculescu M; Simionescu L; Constantinovici A; Login SS; Simionescu N; Dimitriu V; Oprescu M; Grigorescu F
    Endocrinologie; 1979; 17(3):205-11. PubMed ID: 504962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal evidence for the dissemination through the cerebrospinal fluid, of secreting cells from invasive pituitary adenomas.
    Coculescu M; Temel E; Oprescu M; Constantinovici A; Carp N; Simiónescu N
    Endocrinologie; 1981; 19(2):129-35. PubMed ID: 7256167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
    Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
    J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suprasellar extension of tumor associated with increased cerebrospinal fluid activity of growth hormone.
    Hanson EJ; Miller RH; Randall RV
    Mayo Clin Proc; 1976 Jul; 51(7):412-6. PubMed ID: 933557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of growth hormone and thyroid-stimulating hormone in cerebrospinal fluid and pathological compartments of the central nervous system.
    Schaub C; Bluet-Pajot MT; Szikla G; Lornet C; Talairach J
    J Neurol Sci; 1977; 31(1):123-31. PubMed ID: 833608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed TSH- and HGH-secreting pituitary adenoma.
    Coculescu M; Pop A; Constantinovici A; Oprescu M; Temeli E; Marinescu I
    Endocrinologie; 1982; 20(3):209-16. PubMed ID: 7146814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary hormone concentrations in cerebrospinal fluid in patients with prolactin and growth hormone-secreting tumors.
    Rolandi E; Perria C; Cicchetti V; Sannia A; Magnani G; Rivano C; Michelozzi G; Barreca T
    J Neurosurg Sci; 1982; 26(3):173-8. PubMed ID: 7182436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endocrinological evaluation of sellar and suprasellar tumor cases (the ninth report)--on the PRL levels in the CSF (author's transl)].
    Matsumura S; Mori S; Yoshimoto H; Ohta M; Uozumi T
    No Shinkei Geka; 1977 Sep; 5(10):1057-63. PubMed ID: 909617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of acromegaly by transsphenoidal surgery.
    Tucker HS; Grubb SR; Wigand JP; Watlington CO; Blackard WG; Becker DP
    Arch Intern Med; 1980 Jun; 140(6):795-802. PubMed ID: 7387274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the cerebrospinal fluid hGH level in suprasellar extension of pituitary hGH-secreting tumor].
    Shi YF
    Zhonghua Nei Ke Za Zhi; 1983 Oct; 22(10):607-10. PubMed ID: 6673929
    [No Abstract]   [Full Text] [Related]  

  • 12. Human growth hormone levels in cerebrospinal fluid.
    Linfoot JA; Garcia JF; Wei W; Fink R; Sarin R; Born JL; Lawrence JH
    J Clin Endocrinol Metab; 1970 Aug; 31(2):230-2. PubMed ID: 5424662
    [No Abstract]   [Full Text] [Related]  

  • 13. CSF prolactin determination in patients following operation for pituitary tumor.
    Jordan RM; Kendall JW; McDonald SD
    Surg Neurol; 1980 Nov; 14(5):387-91. PubMed ID: 6255621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical study of the pineal hormone melatonin in patients with growth hormone or prolactin secreting pituitary tumours.
    Lissoni P; Mainini E; Rovelli F; Mazzi C; Ardizzoia A; Gelosa M; Capra M; Rivolta MR
    Eur J Med; 1992 Nov; 1(7):407-10. PubMed ID: 1341480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors.
    Shi Y; Tang D; Deng J; Su C
    Chin Med J (Engl); 1998 Oct; 111(10):891-4. PubMed ID: 11189233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of human growth hormone: technique and application to plasma, cerebrospinal fluid, and pituitary extracts.
    Thomas FJ; Lloyd HM; Thomas MJ
    J Clin Pathol; 1972 Sep; 25(9):774-82. PubMed ID: 5086220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thyrotropin-releasing factor on serum thyroid-stimulating hormone. An approach to distinguishing hypothalamic from pituitary forms of idiopathic hypopituitary dwarfism.
    Costom BH; Grumbach MM; Kaplan SL
    J Clin Invest; 1971 Oct; 50(10):2219-25. PubMed ID: 4330007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
    Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
    J Med; 1986; 17(1):25-39. PubMed ID: 3035040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.